<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Tue, 07 Oct 2025 11:12:22 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</title><link>https://www.benzinga.com/trading-ideas/dividends/25/10/48071443/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-d</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/07/Real-Estate-Builds-Long-Term-Equity.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Tue, 07 Oct 2025 12:56:50 GMT</pubDate></item><item><title>This Spire Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday</title><link>https://www.benzinga.com/analyst-stock-ratings/initiation/25/10/48071399/this-spire-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/07/Side-View-Of-Concentrated-Crypto-Trader-.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Tue, 07 Oct 2025 12:49:49 GMT</pubDate></item><item><title>EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial</title><link>https://www.benzinga.com/news/health-care/25/10/48071376/exclusive-envoy-medical-cuts-capital-needs-after-fda-approval-for-final-trial-stage-of-cochlear-</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/07/Medical-Development-Laboratory-Caucasian.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Envoy Medical secured FDA approval to expand its Acclaim cochlear implant trial, accelerating timelines and reducing capital needs by up to $15 millio...</description><pubDate>Tue, 07 Oct 2025 12:46:08 GMT</pubDate></item><item><title>This Netflix Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday</title><link>https://www.benzinga.com/analyst-stock-ratings/upgrades/25/10/48071342/this-netflix-analyst-turns-bullish-here-are-top-4-upgrades-for-tuesday</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/07/Netflix-Faces-UOKiK-Fines.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>read more</description><pubDate>Tue, 07 Oct 2025 12:42:34 GMT</pubDate></item><item><title>The Case for NCIQ ETF: A Rules-Based Approach To Multi-Asset Crypto Investing</title><link>https://www.benzinga.com/Opinion/25/10/48071326/the-case-for-nciq-etf-a-rules-based-approach-to-multi-asset-crypto-investing</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>read more</description><pubDate>Tue, 07 Oct 2025 12:40:16 GMT</pubDate></item></channel></rss>